Complete revascularization in stable multivessel coronary artery disease: A real world analysis from the British

M Bilal Iqbal1,2,3, Peter T Moore1,2, Imad J Nadra1,2

  • 1Victoria Heart Institute Foundation, Victoria, British Columbia, Canada.

Insights

Complete revascularization (CR) in patients with multivessel disease (MVD) undergoing percutaneous coronary intervention (PCI) significantly reduces long-term mortality. This survival benefit is particularly evident in higher-risk patient subgroups.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Multivessel disease (MVD) is common in patients undergoing percutaneous coronary intervention (PCI).
  • The prognostic value of PCI in stable MVD patients is debated.
  • Limited data exists on the benefit of complete revascularization (CR) in stable MVD.

Purpose of the Study:

  • To investigate the prognostic benefit of CR versus incomplete revascularization (IR) in patients with stable MVD undergoing PCI.
  • To identify patient subgroups that may benefit most from CR.

Main Methods:

  • Retrospective analysis of 8,436 patients with MVD undergoing PCI.
  • Comparison of CR versus IR, with all-cause mortality at 5 years as the primary outcome.
  • Multivariable-adjusted analyses and propensity-matched cohort analyses were performed.

Main Results:

  • CR was achieved in 17% of patients.
  • CR was associated with significantly lower 5-year all-cause mortality (6.2% vs. 10.7%) and repeat revascularization rates (12.7% vs. 18.4%).
  • Adjusted analyses confirmed CR as an independent predictor of lower mortality (HR=0.73) and repeat revascularization (HR=0.78).

Conclusions:

  • CR is an independent predictor of long-term survival in stable patients with MVD undergoing PCI.
  • The survival benefit of CR is pronounced in higher-risk patients, including older individuals, males, those with severe angina or heart failure symptoms, and greater coronary disease burden.
  • CR may benefit selected stable MVD patients, warranting consideration in treatment planning.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...